Company Profile
Public information reviewed
Celldex Therapeutics, Inc.
Canonical company identity and public leadership record.
USNASDAQ: CLDX
Follow
More
- Public sources
- 1 reviewed
- Published leadership records
- 19
- Last reviewed
- Sep 20, 2026
Agent View
Machine representations
Inspect the same governed public record as Markdown, structured data, or a retrieval endpoint.
Markdown
https://registry.alpha.ac/companies/celldex-therapeutics-inc.mdCelldex Therapeutics, Inc.
Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.
Record
| Field | Value |
|---|---|
| Representation | alpha-profile-markdown-v3 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1 |
| Canonical entity | alpha:company:833aa779-27d5-474d-a159-7eb59f3dc3cb |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/celldex-therapeutics-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 22 |
| Claims under review | 1 |
| Evidence records | 4 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-09-20T04:45:51.509003+00:00 |
| Last reviewed | 2026-09-20T04:45:51.509003+00:00 |
Identity
- Legal name: Celldex Therapeutics, Inc.
- Display name: Celldex Therapeutics, Inc.
Leadership
- Harry H. Penner, Jr.: Chairman of the Board. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:2.
- Anthony S. Marucci: President, Chief Executive Officer and Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:2.
- Cheryl L. Cohen: Director. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:3.
- Denice Torres: Director. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:3.
- Garry A. Neil: Director. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:3.
- Garry A. Neil, M.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:2.
- Herbert J. Conrad: Director. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:3.
- James J. Marino: Director. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:3.
- Keith L. Brownlie: Director. Valid from: 1997-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:3.
- Rita I. Jain: Director. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:3.
- Rita I. Jain, M.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:2.
- Anthony S. Marucci: President and Chief Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:2.
- Elaine D. Crowley: Senior Vice President, Chief Product Development Officer. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:4.
- Elizabeth Crowley: Senior Vice President and Chief Product Development Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:2.
- Margo Heath-Chiozzi: Senior Vice President, Regulatory Affairs. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:4.
- Margo Heath-Chiozzi, M.D.: Senior Vice President, Regulatory Affairs. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:2.
- Sam Martin: Senior Vice President, Chief Financial Officer and Secretary. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:2.
- Tibor Keler: Executive Vice President and Chief Scientific Officer. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:4.
- Tibor Keler, Ph.D.: Executive Vice President and Chief Scientific Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:2.
Roles
- PUBLISHED
Governance
- NOT_ASSERTED
Board committees
- PUBLISHED
Financials
- NOT_ASSERTED
Workforce
- NOT_ASSERTED
Market and index context
- PUBLISHED
Legal Name
- Celldex Therapeutics, Inc.. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:1.
Headquarters
- US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review.
Entity Status
- Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:1.
Published Fact
- US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:1.
Coverage states
| Field | Value |
|---|---|
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |
Public sources
- alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:1: Alpha canonical company public projection.
- alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:2: SEC DEF 14A 0001104659-26-050884.
- alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:3: DEF 14A tm261321-3_def14a.htm.
- alpha:evidence:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:4: CLDX DEF 14A executive officers.
Rights
| Field | Value |
|---|---|
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |
Limitations
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
Alternate representations
- Canonical profile
- Public Markdown
- Public JSON
- JSON-LD
- MCP resource:
alpha://companies/celldex-therapeutics-incat https://mcp.alpha.ac/mcp